---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-21-001333"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2021-09-22T23:59:59+00:00"
generated_at: "2026-06-29T02:03:14.298522+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioSig appoints med device veteran James Barry as independent director

## Summary
- James J. Barry, Ph.D., appointed to Board effective Sept 20, 2021, filling expanded 7-member board.
- Dr. Barry has 30+ years in med devices; former SVP at Boston Scientific, President/CEO at InspireMD and Arsenal Medical.
- Received 50,000 RSUs—50% vested immediately, 50% on first anniversary.
- Over 60 physicians have completed 1,300+ patient cases with PURE EP system across 12 clinical sites.
- Commercial launch focused in Northeast, Texas, Florida; in use at Mayo Clinic and St. David's Medical Center.

## SEC filing metadata
- accession: 0001185185-21-001333
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2021-09-22T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518521001333/0001185185-21-001333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518521001333/biosig20210921_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-21-001333
- JSON: https://secwatch.observer/filing/0001185185-21-001333.json
- Plain text: https://secwatch.observer/filing/0001185185-21-001333.txt

## Key facts
- Executive change
  James J. Barry was appointed as director at Streamex Corp..
  - Action: appointed
  - Role: director
  source text: On September 20, 2021, the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) appointed James J. Barry, Ph.D. as a director of the Company, effective as of the same date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518521001333/0001185185-21-001333-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.